Guanidinobenzoatase and UPA in high-grade human astrocytomas and after xenografting cell suspensions into the rat cerebral cortex: Proteases for metastasis and disease progression

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2583-2590

  Bernstein, Lerald J ^a,c,f,g   Tonn, Jörg Christian ^d,e   Goldbrunner, Roland H ^d,e   Vince, Giles H ^d,e   Wagner, Sven ^d,e   Goldberg, William J ^b,c  

^a Lab Ctrl Nerv Syst R   (United States)

^b Lab of the Animal Research Facility   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g Department of Neurosurgery ^*  (Germany)

Author keywords

Astrocytes; Astrocytoma; C6; Glioblastoma; Guanidinobenzoatase; Immunohistochemistry; Protease

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; GUANIDINE DERIVATIVE; PROTEINASE; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA; BLOOD VESSEL; BRAIN CORTEX; CELL MIGRATION; CELL SUSPENSION; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE COURSE; EXTRACELLULAR MATRIX; GLIA; HUMAN TISSUE; MALE; METASTASIS; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TUMOR XENOGRAFT;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; CARBOXYLIC ESTER HYDROLASES; CEREBROVASCULAR CIRCULATION; DISEASE PROGRESSION; ENDOPEPTIDASES; GLIOBLASTOMA; HUMANS; MALE; MICROSCOPY, CONFOCAL; NEOPLASM METASTASIS; RATS; RATS, NUDE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0031810470     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Anees M: Interaction of tissue plasminogen activator inhibitor with cell surface guanidinobenzoatase and urokinase plasminogen activator. J Enzyme Inhib 10: 281-288, 1996.
2. Bernstein JJ, Goldberg WJ, Laws ERJ, Conger D, Morreale V and Wood L: C6 glioma cell invasion and migration in rat brain after neural homografting: Ultrastructure. Neurosurgery 26: 622-628 1990.
3. Bernstein JJ, Laws ERJ, Levine K, Wood L, Tadvalkar G and Goldberg WJ: C6 glioma-astrocytoma cell and fetal astrocyte migration into artificial basement membrane: A permissive substrate for neural tumors but not fetal astrocytes. Neurosurgery 28: 652-658, 1991.
4. Bernstein JJ, Anagnostopoulos A, Hattwick E and Laws ERJ: Human specific c-neu proto-oncogene protein is overexpressed by human malignant astrocytomas before and after xenografting into rat brain. J Neurosurg 78: 240-251, 1993.
5. Bernstein JJ, Goldberg WJ and Laws ER: Human malignant astrocytoma xenografts migrate in rat brain: A model for central nervous system cancer research. J Neurosci Res 22: 134-144, 1989a.
6. Bernstein JJ, Goldberg WJ and Laws ERJ: Immunohistochemistry of a human malignant astrocytoma xenografted to rat brain. Neurosurgery 24: 541-546, 1989b.
7. Bernstein JJ, Goldberg WJ and Laws ERJ: Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro. J Neurooncol 18: 151-161, 1994.
8. Bindal AK, Hammoud M, Shi WM, Wu SZ, Sawaya R and Rao JS: Prognostic significance of proteolytic enzymes in human brain tumors. [Review]. Journal of Neuro Oncology 22: 101-110, 1994.
9. Cohen A and Schwartz M: Conditioned media of regenerating fish optic nerves modulate laminin levels in glial cells. J Neurosci Res 22: 269-273, 1989.
10. Dano K, Dabelsteen E, Nielsen LS, Kaltoft K, Wilson EL and Zeuthen J: Plasminogen activating enzyme in cultured glioblastoma cells. J Histochem Cytochem 30: 1165-1170, 1982.
11. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS and Skriver L (1985). Plasminogen activators, tissue degradation, and cancer. In: Advances in Cancer Research. (Ed. by Klein, G. & Weinhouse, S.), 139 Academic Press, Inc. New York.
12. Finkelstein SD, Black P, Nowak TP, Hand CM, Christensen S & Finch PW: Histological characteristics and expression of acidic and basic fibroblast growth factor genes in intracerebral xenogeneic transplants of human glioma cells. Neurosurgery 34: 136-143, 1994.
13. Go KG, Chintala SK, Mohanam S, Gokaslan ZL, Venkaiha B, Bjerkvig R, Oka K, Nicholson GL, Sawaya R and Rao JS: Inhibition of in vivo tumorigenicity and invasiveness of a human glioblastoma cell line transfected with antisense uPAR vectors. Clin Exp Med 15: 440-446, 1997.
14. Goldberg WJ, Laws ERJ, Levine K, Tadvalkar G and Bernstein JJ: Mechanisms of C6 glioma and fetal astrocyte migration into hydrated collagen gels. Brain Res 581: 81-90, 1992.
15. Goldberg WJ, Laws ERJ, and Bernstein JJ: Individual C6 glioma cells migrate in adult rat brain after neural homografting. Int J Dev Neurosci 9: 427-436, 1991.
16. Gross JL, Berens DL, Mullins DE, Kornblith PL and Dexter DL: Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. CancerRes 48: 291-296, 1988.
17. Hince T and Roscoe J: Differences in pattern and level of plasminogen activator production between a cloned cell line from a ethylnitrosourea-induced glioma and one from normal adult rat brain. J Cell Physiol 104: 199-207, 1980.
18. Hollas W, Blasi F and Boyd D: Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res 57: 3690-3695, 1991.
19. Kleihues P, Burger PC and Scheithauer BW: The New WHO Classification of Brain Tumors. Brain Pathology 3: 255-268, 1993.
20. Laws ERJ, Goldberg WJ and Bernstein JJ: Migration of human astrocytoma cells in the mammalian brain: Scherer revisited. Int J Devel Neurosci 11: 691-697, 1993.
21. Liepkalns V, Icard-Liepkalns C, Sommer A and Quigley J: Properties of cloned human glioblastoma cells. Release of a specific protease. J Neurol Sci 57: 257-264, 1982.
22. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V and Garbisa S: Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636, 1981.
23. Mackay AR, Corbitt RH, Hartzler JL and Thorgeirsson UP: Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metallo-proteinases. Cancer Res 50: 5997-6001, 1990.
24. Mignatti P, Robbing E and Rifkin D: Tumor cell invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487-498, 1986.
25. Nielsen LS, Hansen JG, Skriver L, Wilson EL, Kaltoft K, Zeuthen J and Dano K: Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochem 21: 6410-6415, 1982.
26. Ossowski L and Reich E: Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35: 611-619, 1983.
27. Pauli BU and Knudson W: Tumor invasion: A consequence of destructive and compositional matrix alterations. Hum Pathol 19: 628-639, 1988.
28. Poustis-Delpont C, Thaon S, Auberger P, Gerardi-Laffin C, Sudaks P and Rossi B: Monomeric 55-kDa guanidinobenzoatase switches to a serine protease activity upon tetramerization. Tetrameric SP 220 K appears as the native form. J Biol Chem 269: 14666-14671, 1994.
29. Quidlen EA and Bucher AP: Correlation of tumor plasminogen activator with peritumoral cerebral edema. A CT and biochemical study. J Neurosurg 66: 729-733, 1987.
30. Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta LA and Sawaya R: Role of plasminogen activator and of 92 kDa type IV collagenase in glioblastoma invasion using an in vitro Matrigel model. J Neuro-Oncol 18: 129-138, 1994.
31. Romer J, Pyke C, Lund LR, Eriksen J, Kristensen P, Ronne E, Hoyer-Hansen G, Dano K and Brunner N: Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion. Int J Cancer 57: 553-560, 1994.
32. Salo T, Liotta LA, Keski-Oja J, Turpeenniemi-Hujanen T and Tryggvason K: Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells - role in metastasis. Int J Cancer 30: 669-673, 1982.
33. Scherer H: The forms of growth in gliomas and their practical significance. Brain 63: 1-35, 1940a.
34. Scherer H: Cerebral astrocytomas and their derivatives. Am J Cancer 40: 159-197, 1940b.
35. Scherer H.J.: A critical review, the pathology of cerebral gliomas. J Neurology Psychiat 3: 147-177, 1940.
36. Schwechheimer K, Laufle RM, Schmahl W, Knodlseder M, Fischer H and Hofler H: Expression of neu/c-erbB-2 in human brain tumors. Human Pathology 25: 772-780, 1994.
37. Sitrin RG, Gyetko MR, Kole KL, McKeever P and Varani J: Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines. Cancer Res 50: 4957-4961, 1990.
38. Steven FS, Griffin MM, Maier H, Weidauer H, Mangel WF and Altmannsberger M: Studies on the activity of a protease associated with cells at the advancing edge of human tumour masses in frozen sections. Br J Cancer 58: 57-60, 1988.
39. Steven FS, Anees M and Booth NA: Selectivity of the plasminogen activator inhibitor (PAI-1) for the iso enzyme of guanidinobenzoatase on the surface of colonie carcinoma cells. Anticancer Res 15: 205-210, 1995.
40. Steven FS, Griffin M and Al-Ahmad R: The design of fluorescent probes which bind to the active centre of guanidinobenzoatase. Eur J Biochem 149: 35-40, 1985.
41. Steven FS, Griffin MM and Talbot IC: GB (guanidinobenzoatase) cell surface protease and serum inhibitors in colorectal neoplasia. J Pathol 167: 19-24, 1992.
42. Tryggvason K, Hoyhta M and Salo T: Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907: 191-217, 1987.
43. Vriesendorp F, Groothuis D and Bigner DD: Concurrent measurements of blood flow and transcapillary transport in xenotransplanted human gliomas in immunosuppressed rats. J Natl Cancer Inst 79: 123-130, 1987.
44. Wilson EL, Becker MLB, Hoal EG and Dowdle EB: Molecular species of plasminogen activators secreted by normal and neoplastic human cells. Cancer Res 40: 933-938, 1980.
45. Wilson EL and Dowdle E: Secretion of plasminogen activator by normal, reactive and neoplastic human tissues cultured in vitro. Int J Cancer 22: 390-399, 1978.
46. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL and Rao JS: Expression and localization of urokinasetype plasminogen activator receptor in human gliomas. Cancer Res 54: 5016-5020, 1994.
47. Yu H and Schultz RM: Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. Cancer Res 50: 7623-7633, 1990.
48. Zanker KS, Stavrou D, Osterkakmp U, Wriedt-Lubbe I and Blumel G: Fibrinolysis induced by rat glioma cells. A mitosis-triggered process? J Neurol Sci 38: 67-75, 1978.